OR13J1

Across TCGA pan-cancer cohorts, OR13J1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of OR13J1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where OR13J1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR13J1 is over-expressed in tumor, although a few such as PRAD and ESCA show the opposite, repressed pattern.

THCA, BRCA, and KIRC are the cancer types where OR13J1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR13J1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	+0.095	<.001	7	view →
BRCA	All	II,III,IV	+0.216	<.001	6	view →
KIRC	Female	II,III,IV	+0.081	.006	6	view →
KICH	All	All	+0.095	.001	4	view →
COAD	Female	All	+0.125	.009	2	view →
PRAD	All	All	−0.049	.040	2	view →
ESCA	Female	All	−0.116	.029	1	view →
CHOL	All	All	+0.079	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

OR13J1–THCA

Open the THCA breakdown →